Pseudomonas aeruginosa induces localized immunosuppression during pneumonia - Wikidata - wikimedia - TriplyDB

Pseudomonas aeruginosa induces localized immunosuppression during pneumonia

Pseudomonas aeruginosa induces localized immunosuppression during pneumonia

http://www.wikidata.org/entity/Q30483670

about

Biosynthesis of UDP-GlcNAc(3NAc)A by WbpB, WbpE, and WbpD: enzymes in the Wbp pathway responsible for O-antigen assembly in Pseudomonas aeruginosa PAO1 Bacterial Sphingomyelinases and Phospholipases as Virulence Factors Association between Pseudomonas aeruginosa type III secretion, antibiotic resistance, and clinical outcome: a review In the absence of effector proteins, the Pseudomonas aeruginosa type three secretion system needle tip complex contributes to lung injury and systemic inflammatory responses Structural Analysis of WbpE from Pseudomonas aeruginosa PAO1: A Nucleotide Sugar Aminotransferase Involved in O-Antigen Assembly,RahU: an inducible and functionally pleiotropic protein in Pseudomonas aeruginosa modulates innate immunity and inflammation in host cells Why is Pseudomonas aeruginosa a pathogen?The hemolytic and cytolytic activities of Serratia marcescens phospholipase A (PhlA) depend on lysophospholipid production by PhlA.Activation of ExoU phospholipase activity requires specific C-terminal regions.Discovery and characterization of inhibitors of Pseudomonas aeruginosa type III secretion.Cheating by type 3 secretion system-negative Pseudomonas aeruginosa during pulmonary infection.The ADP-ribosyltransferase domain of the effector protein ExoS inhibits phagocytosis of Pseudomonas aeruginosa during pneumonia Pseudomonas aeruginosa cytotoxin ExoU is injected into phagocytic cells during acute pneumonia.Pathogenicity islands PAPI-1 and PAPI-2 contribute individually and synergistically to the virulence of Pseudomonas aeruginosa strain PA14 Role of the membrane localization domain of the Pseudomonas aeruginosa effector protein ExoU in cytotoxicity An rhs gene of Pseudomonas aeruginosa encodes a virulence protein that activates the inflammasome.ExoU activates NF-κB and increases IL-8/KC secretion during Pseudomonas aeruginosa infection.Airway epithelial MyD88 restores control of Pseudomonas aeruginosa murine infection via an IL-1-dependent pathway.Innate immune responses to Pseudomonas aeruginosa infection.The Role of ExoS in Dissemination of Pseudomonas aeruginosa during Pneumonia.ExoS and ExoT ADP ribosyltransferase activities mediate Pseudomonas aeruginosa keratitis by promoting neutrophil apoptosis and bacterial survival.Rampant Cheating by Pathogens?Contribution of the platelet activating factor signaling pathway to cerebral microcirculatory dysfunction during experimental sepsis by ExoU producing Pseudomonas aeruginosa.Innate Immune Signaling Activated by MDR Bacteria in the Airway Type III secretion of ExoU is critical during early Pseudomonas aeruginosa pneumonia.Sugar administration is an effective adjunctive therapy in the treatment of Pseudomonas aeruginosa pneumonia Matrix metalloproteases in bronchoalveolar lavage fluid of patients with type III Pseudomonas aeruginosa pneumonia.Concurrent lung infections in patients with hematological malignancies and invasive pulmonary aspergillosis: how firm is the Aspergillus diagnosis?The type III secretion system of Pseudomonas aeruginosa: infection by injection.Pseudomonas aeruginosa virulence and antimicrobial resistance: two sides of the same coin?Insulin treatment modulates the host immune system to enhance Pseudomonas aeruginosa wound biofilms.Hypercapnia impairs lung neutrophil function and increases mortality in murine pseudomonas pneumonia.PrtR homeostasis contributes to Pseudomonas aeruginosa pathogenesis and resistance against ciprofloxacin.Structure and function of the Type III secretion system of Pseudomonas aeruginosa.Pneumonia pathogen detection and microbial interactions in polymicrobial episodes.ExoU-induced redox imbalance and oxidative stress in airway epithelial cells during Pseudomonas aeruginosa pneumosepsis.Central role of PAFR signalling in ExoU-induced NF-κB activation.Inflammation: A Double-Edged Sword in the Response to Pseudomonas aeruginosa Infection.Regulation of Rab5 function during phagocytosis of live Pseudomonas aeruginosa in macrophages.The contribution of Pseudomonas aeruginosa virulence factors and host factors in the establishment of urinary tract infections.

P2860

Q24648470-63651E05-B4DD-472A-93A0-1D3810116579 Q26745804-378A88F2-2331-4BBD-8041-FF95A73C42BF Q27013824-D973F5F0-89F6-4BC5-BC0D-9DC9F9AA8C0B Q27300857-7A780E1A-40B6-4FF4-A322-1F7E903501C4 Q27663161-869F5545-427D-41A4-9C27-38748C9753A2 Q30425067-A9892BBF-9438-469D-A175-FE688A099EC0 Q30434529-10C0F9B5-A5D2-4E15-A95D-3E0C6C478C27 Q33518058-B2BB336B-F92F-4C14-8BB8-9469D69ADFA4 Q33526200-B53EC696-8BAC-42D4-B8A5-944FF3416E58 Q33533545-3CDB7ABC-E51C-414C-8A98-C6C8DEBD4AC1 Q33694537-86E602F4-32C5-4612-A3E5-E54FE6B60109 Q33751840-4B0F2054-6B0E-4644-997F-9DBD956F22E6 Q33769046-2FA2DCE3-E7A3-4036-8F91-EFFBBCA0009F Q33769060-69D12DE7-B42F-4A73-8F1F-745F3EDD4BA8 Q34045056-BFE42985-6A26-4EB1-B9A2-1342EEC42D2F Q34246078-A27842BB-F4F7-4F2D-BE5E-68587EE62D4A Q34358987-93C16387-9117-4EC2-BBED-F11A2C085DDD Q35032790-DE11C2E7-3F11-45C3-BF17-2E35050918B1 Q35566398-3F7A1250-596D-422E-B1B0-CC95883EBD88 Q35668315-FA35071D-CE1E-47BA-A896-E57FB9BA1ACC Q35740028-B580AF67-D4DE-4230-900F-E1C376176425 Q36126212-46A6FE45-5AE2-47C3-9F5A-C7972DB305A4 Q36226452-53B8D25E-556E-47B9-B963-5F5832A90E7D Q36422470-7910DA6A-AC24-4571-A85E-C014D808C021 Q36706278-FC15D77B-8A39-435E-8F29-C9B9D892F325 Q37147088-E9BFFD69-964F-449C-ADA0-56E6F6520F12 Q37373550-F0B87DCF-802B-4213-A780-CA2C37FAD53C Q37373785-755C6F5E-301E-452C-803E-F20FF790CC2A Q37397923-86106EC8-7685-48B1-9521-4A24AA4B8C34 Q37402651-E0BFCD11-2A34-47D2-B92D-BCCE6119BE46 Q37548115-41E6B5D6-4DFF-467A-887C-C2A0EC65C51E Q37596440-3B8CBBAA-1337-4590-9809-DBAE79751A49 Q37713295-8E8C0EA4-6B27-4802-A96F-630E1DF088F8 Q38072996-48BACC92-F5A7-4894-B596-8A9063A9FFDC Q38103941-D555CCE9-F802-457A-AEC2-561E5E8BDEE2 Q38883284-0543833A-7B28-4242-BC8F-396671CA08DC Q39017043-215F35B4-AEAC-4997-9058-26BB114C98E6 Q39145412-9720CE9B-1701-4573-A5C2-FA19FE546D90 Q39158295-5BF8EA49-DC33-4832-BD2F-BC8674B0CB81 Q39367045-E775D265-C4BC-47AF-A59E-6FEDC2ACA81D

P2860

Pseudomonas aeruginosa induces localized immunosuppression during pneumonia

http://www.wikidata.org/entity/Q30483670

description

2008 nî lūn-bûn

@nan

2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Pseudomonas aeruginosa induces localized immunosuppression during pneumonia

@ast

Pseudomonas aeruginosa induces localized immunosuppression during pneumonia

@en

type

label

Pseudomonas aeruginosa induces localized immunosuppression during pneumonia

@ast

Pseudomonas aeruginosa induces localized immunosuppression during pneumonia

@en

prefLabel

Pseudomonas aeruginosa induces localized immunosuppression during pneumonia

@ast

Pseudomonas aeruginosa induces localized immunosuppression during pneumonia

@en

P1433

Q30483670-78C69AD3-4BFF-4DA0-A846-0A354E1BFCEF

P1476

Q30483670-8C84A7CD-457D-4B14-90B2-006D3A09A1EA

P2093

Q30483670-131935A3-5A45-42C7-AFBF-015793E7F66B

Q30483670-177E074A-CC10-45B2-AFC1-1DDBBA4F43B3

Q30483670-21FC84EE-F2BF-4F2B-9B12-CDDE89590A22

Q30483670-3A55D3C7-FDEB-4C7D-A2E9-D8EF6C646D07

Q30483670-A6978BD0-BCFE-4828-A4EC-835D80C96B63

P2860

Q30483670-0FA7A40D-D580-4740-AE8B-8C48AEAD29E6

Q30483670-1418DEA1-B725-45E0-8351-86438673E106

Q30483670-16BA1DEB-5BCD-485F-BDE1-D49E9315EF8B

Q30483670-20BE5F72-354D-45B3-9DEE-010DF1E337F3

Q30483670-2646CD10-A812-4AA8-AD86-7C50562C2673

Q30483670-2D1A8078-7581-4A09-92B7-EE5C65F371B6

Q30483670-3012041A-7ECB-4AF7-9DC5-0F42840E604D

Q30483670-32F383E8-5B41-4969-AFD9-8E90C9EA7D72

Q30483670-3B3B7CC7-10D6-4FAA-9916-4A04C3503661

Q30483670-3B7DB442-54CB-4086-9CAC-7B1887E200F1

P304

Q30483670-FA141745-90A9-4C23-A062-D94DDB7D7F23

P31

Q30483670-3172B54A-FB0E-4C3F-BDE0-4389B3F6E2FF

P356

Q30483670-848E9E7E-E790-42A8-A3BC-9F77386F16BE

P407

Q30483670-68CA4251-001D-4D98-8083-8A23A21CA678

P433

Q30483670-3BDB42E7-7E3C-4624-8090-2A883967149A

P478

Q30483670-A40DDFF7-4CA9-4C89-BDDB-483BAD61E429

P50

Q30483670-02E80687-F084-45B8-A0B7-C10593E9A25B

P577

Q30483670-C76E09BD-556B-4DD3-92FE-03CAB27B3223

P5875

Q30483670-7E5F972C-5DE8-4E16-ADA7-B7937DB53A70

P698

Q30483670-02315747-AAF7-4906-B211-AFD6544BF81D

P921

Q30483670-6908F9DB-198D-4DEB-A92F-9614402B0853

Q30483670-BDF0ABF0-06E7-4FC5-B06B-5DBC35F9328E

Q30483670-D0C22B24-8078-4427-88A3-02FDD9399AE0

P932

Q30483670-9D59CB43-C8F7-4869-841D-BCEC3EBC099C

P356

P1433

Infection and Immunity

P1476

Pseudomonas aeruginosa induces localized immunosuppression during pneumonia

@en

P2093

Alan R Hauser

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Kazzaz

http://www.w3.org/2001/XMLSchema#string

John D King

http://www.w3.org/2001/XMLSchema#string

Maureen H Diaz

http://www.w3.org/2001/XMLSchema#string

Srinidhi Musunuri

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

Pseudomonas aeruginosa gene products PilT and PilU are required for cytotoxicity in vitro and virulence in a mouse model of acute pneumonia

Acetylornithinase of Escherichia coli: partial purification and some properties

Lung infections associated with cystic fibrosis.

Pseudomonas aeruginosa induces type-III-secretion-mediated apoptosis of macrophages and epithelial cells.

Pseudolipasin A is a specific inhibitor for phospholipase A2 activity of Pseudomonas aeruginosa cytotoxin ExoU.

Functional regions of the Pseudomonas aeruginosa cytotoxin ExoU

Acquisition of expression of the Pseudomonas aeruginosa ExoU cytotoxin leads to increased bacterial virulence in a murine model of acute pneumonia and systemic spread

CXC chemokine receptor CXCR2 is essential for protective innate host response in murine Pseudomonas aeruginosa pneumonia.

Activities of Pseudomonas aeruginosa effectors secreted by the Type III secretion system in vitro and during infection

P304

4414-4421

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/IAI.00012-08

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

76

http://www.w3.org/2001/XMLSchema#string

P50

Ciara Martin Shaver

P577

2008-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23133613

http://www.w3.org/2001/XMLSchema#string

P698

18663007

http://www.w3.org/2001/XMLSchema#string

P921

immunosuppression

Pseudomonas aeruginosa

P932

2546837

http://www.w3.org/2001/XMLSchema#string